← All news
Markets
Eli Lilly’s $100B incretin opportunity: Is more upside coming?
Covered by 1 outlet
All coverage · 3 articles
Investing.com Canada
·Sep 6, 21:52 UTC
Eli Lilly’s $100B incretin opportunity: Is more upside coming?
Investing.com UK
·Sep 6, 21:52 UTC
Eli Lilly’s $100B incretin opportunity: Is more upside coming?
Investing.com Stock Market
·Sep 6, 21:19 UTC